Skip to Content
Merck
  • Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.

Nature communications (2020-08-01)
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice André, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
ABSTRACT

Hormone receptor (HR)+ breast cancer (BC) causes most BC-related deaths, calling for improved therapeutic approaches. Despite expectations, immune checkpoint blockers (ICBs) are poorly active in patients with HR+ BC, in part reflecting the lack of preclinical models that recapitulate disease progression in immunocompetent hosts. We demonstrate that mammary tumors driven by medroxyprogesterone acetate (M) and 7,12-dimethylbenz[a]anthracene (D) recapitulate several key features of human luminal B HR+HER2- BC, including limited immune infiltration and poor sensitivity to ICBs. M/D-driven oncogenesis is accelerated by immune defects, demonstrating that M/D-driven tumors are under immunosurveillance. Safe nutritional measures including nicotinamide (NAM) supplementation efficiently delay M/D-driven oncogenesis by reactivating immunosurveillance. NAM also mediates immunotherapeutic effects against established M/D-driven and transplantable BC, largely reflecting increased type I interferon secretion by malignant cells and direct stimulation of immune effector cells. Our findings identify NAM as a potential strategy for the prevention and treatment of HR+ BC.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
EGF from mouse, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
LookOut® Mycoplasma PCR Detection Kit, Optimized for use with JumpStart Taq DNA Polymerase, D9307.
Sigma-Aldrich
Citrate Buffer, pH 6.0, 10×, Antigen Retriever, for immunohistochemistry
Sigma-Aldrich
Anti-Atg7 antibody, Mouse monoclonal, clone ATG7-13, purified from hybridoma cell culture
Sigma-Aldrich
Insulin solution from bovine pancreas, 10 mg/mL insulin in 25  mM HEPES, pH 8.2, BioReagent, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Phorbol 12-myristate 13-acetate, ≥99% (TLC), film or powder
Sigma-Aldrich
Formaldehyde solution, for molecular biology, 36.5-38% in H2O
Sigma-Aldrich
Propidium iodide, ≥94.0% (HPLC)
Sigma-Aldrich
Trypan Blue, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
TS/A Mouse Mammary Adenocarcinoma Cell Line, TS/A mouse mammary adenocarcinoma cell line is a well characterized and highly published model for breast cancer research.
Sigma-Aldrich
CRISPR UNIVERSAL NEGATIVE CONTROL 1
Sigma-Aldrich
CRISPR/Cas9 Products and Services, Design and order CRISPR gRNA, Cas9, screening libraries, controls and companion products. Formats include plant, lentivirus, IVT-RNA, plasmid, synthetic, and protein.
Sigma-Aldrich
AT-3 Mouse Mammary Carcinoma Cell Line, AT-3 mouse mammary tumor cell line may be used to develop mouse models for mammary cancer studies.
Mitoxantrone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
RNAlater®, Stabilize and protect RNA with immediate RNase inactivation
Sigma-Aldrich
HistoChoice® Clearing Agent, alternative to toluene and xylene
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Corn oil, delivery vehicle for fat-soluble compounds
Sigma-Aldrich
Tamoxifen, ≥99%
Sigma-Aldrich
Ionomycin calcium salt, Ready Made Solution, from Streptomyces conglobatus, 1 mM in DMSO
Sigma-Aldrich
Xylenes, reagent grade
Sigma-Aldrich
MCA205 Mouse Fibrosarcoma Cell Line, MCA205 mouse fibrosarcoma cell line is an excellent model for studying immune response to tumor cells and the development of targeted cancer immunotherapies.
Sigma-Aldrich
TransIT-CRISPR®